Beta Bionics, Inc. Common Stock BBNX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $110.24M+57.9% | $100.25M+53.9% | $88.57M+85.7% | $78.02M+130% | $69.83M+218% | ||
| $47.24M+46.8% | $44.71M+52.9% | $40.29M+83.9% | $35.95M+131% | $32.17M+222% | ||
| $63M+67.3% | $55.54M+54.8% | $48.28M+87.3% | $42.08M+128% | $37.66M+216% | ||
| 57.2%+3.2pp | 55.4%+0.3pp | 54.5%+0.5pp | 53.9%-0.3pp | 53.9%-0.5pp | ||
| $37.56M+32.7% | $34.79M+32.9% | $33.87M+57.9% | $30.82M+48.2% | $28.3M+49.4% | ||
| $68.74M+60.5% | $61.4M+65.6% | $55.87M+90.8% | $49.47M+119% | $42.83M+157% | ||
| $34.02M+62.2% | $31.03M+73.6% | $27.13M+67.3% | $24.31M+71.6% | $20.98M+65.4% | ||
| $140.31M+52.4% | $127.22M+56.8% | $116.88M+74.6% | $104.61M+81.6% | $92.1M+90.8% | ||
| -$77.31M-42.0% | -$71.68M-58.4% | -$68.59M-66.6% | -$62.53M-59.7% | -$54.44M-49.8% | ||
| -70.1%+7.8pp | -71.5%-2.0pp | -77.4%+8.9pp | -80.1%+35.1pp | -78%+87.8pp | ||
| —— | —— | -$9.25M-42.4% | -$10.84M-10.6% | -$16.52M-79.9% | ||
| -$66.44M+6.4% | -$73.2M-33.7% | -$77.84M-63.3% | -$73.37M-49.9% | -$70.96M-55.9% | ||
| -60.3%+41.4pp | -73%+11.1pp | -87.9%+12.1pp | -94%+50.1pp | -101.6%+106pp | ||
| -$1.50+80.0% | -$1.94+77.5% | -$4.39+45.0% | -$5.52+35.8% | -$7.50+9.7% | ||
| -$75.46M-41.6% | -$70.11M-59.0% | -$67.33M-68.5% | -$61.31M-61.5% | -$53.27M-51.6% | ||
| -68.4%+7.8pp | -69.9%-2.2pp | -76%+7.8pp | -78.6%+33.1pp | -76.3%+83.9pp | ||
| -$77.31M-42.0% | -$71.68M-58.4% | -$68.59M-66.6% | -$62.53M-59.7% | -$54.44M-49.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Beta Bionics, Inc. Common Stock's revenue?
- Beta Bionics, Inc. Common Stock (BBNX) generated $110.2M in revenue over the trailing twelve months, up 57.9% year over year.
- Is Beta Bionics, Inc. Common Stock profitable?
- Beta Bionics, Inc. Common Stock is not currently profitable: it reported a net loss of $66.4M over the trailing twelve months, a -60.3% net margin.
- What are Beta Bionics, Inc. Common Stock's profit margins?
- Gross margin is 57.2% and operating margin is -70.1%, with a -60.3% net margin.
- What is Beta Bionics, Inc. Common Stock's earnings per share?
- Beta Bionics, Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.50.
- Where does Beta Bionics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
